UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 234

Sortiert nach

Mark E. Josephson (1943–2017)

Netherlands heart journal, 2017-04, Vol.25 (4), p.292-292

Hauer, R. N. W.

2017

Link zum Volltext

Verfügbarkeit prüfen

Recurrent and founder mutations in the Netherlands—Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy

Netherlands heart journal, 2013-06, Vol.21 (6), p.286-293

2013

Link zum Volltext

Verfügbarkeit prüfen

Interaction of flucloxacillin and quinidine

European journal of clinical pharmacology, 2012-05, Vol.68 (5), p.891-893

2012

Link zum Volltext

Verfügbarkeit prüfen

Rationale and design of a randomised controlled clinical trial on supplemental intake of n-3 fatty acids and incidence of cardiac arrhythmia: SOFA

European journal of clinical nutrition, 2003-10, Vol.57 (10), p.1323-1330

2003

Link zum Volltext

Verfügbarkeit prüfen

Can optimization of pacing settings compensate for a non-optimal left ventricular pacing site?

Europace (London, England), 2010-09, Vol.12 (9), p.1262-1269

2010

Link zum Volltext

Verfügbarkeit prüfen

Proposed Diagnostic Criteria for the Brugada Syndrome

European heart journal, 2002-11, Vol.23 (21), p.1648-1654

2002

Link zum Volltext

Verfügbarkeit prüfen

Haplotype sharing test maps genes for familial cardiomyopathies

Clinical genetics, 2011-05, Vol.79 (5), p.459-467

2011

Link zum Volltext

Verfügbarkeit prüfen

Recurrent and founder mutations in the Netherlands: Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia

Netherlands heart journal, 2010-12, Vol.18 (12), p.583-591

2010

Link zum Volltext

Verfügbarkeit prüfen

Geographical distribution of plakophilin-2 mutation prevalence in patients with arrhythmogenic cardiomyopathy

Netherlands heart journal, 2012-05, Vol.20 (5), p.234-239

2012

Link zum Volltext

Verfügbarkeit prüfen

The dawn of a new era in the struggle against sudden cardiac death

Netherlands heart journal, 2009-03, Vol.17 (3), p.111-112

Hauer, R N W

2009

Link zum Volltext

Verfügbarkeit prüfen

Genetic and molecular basis of cardiac arrhythmias : Impact on clinical management parts I and II

Circulation (New York, N.Y.), 1999-02, Vol.99 (4), p.518-528

1999

Link zum Volltext

Verfügbarkeit prüfen

Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1)

Journal of the American College of Cardiology, 1999-02, Vol.33 (2), p.327-332

1999

Link zum Volltext

Verfügbarkeit prüfen

The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update

Netherlands heart journal, 2019-10, Vol.27 (10), p.480-486

2019

Link zum Volltext

Verfügbarkeit prüfen

Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study

Europace (London, England), 2003-10, Vol.5 (4), p.381-389

2003

Link zum Volltext

Verfügbarkeit prüfen

Arrhythmogenic right ventricular cardiomyopathy: asymptomatic to life threatening as illustrated by the cases of two sisters

Netherlands heart journal, 2007-10, Vol.15 (10), p.348-353

2007

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation: current knowledge and recommendations for management

European heart journal, 1998-09, Vol.19 (9), p.1294-1320

1998

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation

European heart journal, 2001-03, Vol.22 (5), p.400-409

2001

Link zum Volltext

Verfügbarkeit prüfen

The dawn of a new era in the struggle against sudden cardiac death

Netherlands heart journal, 2009-03, Vol.17 (3), p.111-112

Hauer, R. N. W.

2009

Link zum Volltext

Verfügbarkeit prüfen

Genetic and molecular basis of cardiac arrhythmias : Impact on clinical management. Part III

Circulation (New York, N.Y.), 1999-02, Vol.99 (5), p.674-681

1999

Link zum Volltext

Verfügbarkeit prüfen

Mortality and risk factors for malignant ventricular arrhythmias in carriers of the phospholamban R14del mutation

European heart journal, 2013-08, Vol.34 (suppl 1), p.P2287-P2287

2013

Link zum Volltext

Verfügbarkeit prüfen

Can Implantable Cardioverter-Defibrillator Therapy Reduce Healthcare Costs?

The American journal of cardiology, 1996-09, Vol.78 (5), p.134-139

1996

Link zum Volltext

Verfügbarkeit prüfen

Identification of the substrate of atrial vulnerability in patients with idiopathic atrial fibrillation

Circulation (New York, N.Y.), 2000-03, Vol.101 (9), p.995-1001

2000

Link zum Volltext

Verfügbarkeit prüfen

Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors

Circulation (New York, N.Y.), 1995-04, Vol.91 (8), p.2195-2203

1995

Link zum Volltext

Verfügbarkeit prüfen

Infection after ICD implantation: operating room versus cardiac catheterisation laboratory

Netherlands heart journal, 2009-03, Vol.17 (3), p.95-100

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(206)
Mit Volltextzugriff
(221)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(151)
Life Sciences & Biomedicine
(97)
Physics
(82)
Humans
(75)
Cardiac & Cardiovascular Systems
(70)
Cardiovascular System & Cardiology
(70)
Biological And Medical Sciences
(61)
Medical Sciences
(58)
Nuclear Physics
(56)
Physical Sciences
(55)
Experiment
(52)
High Energy Physics - Experiment
(52)
Nuclear Experiment
(50)
Particle Physics
(50)
Cardiology. Vascular System
(38)
Female
(38)
Heart
(37)
Male
(37)
Physics Of Elementary Particles And Fields
(34)
Cardiac Dysrhythmias
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mark E. Josephson (1943–2017)

Recurrent and founder mutations in the Netherlands—Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy

Interaction of flucloxacillin and quinidine

Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy

Rationale and design of a randomised controlled clinical trial on supplemental intake of n-3 fatty acids and incidence of cardiac arrhythmia: SOFA

Can optimization of pacing settings compensate for a non-optimal left ventricular pacing site?

Proposed Diagnostic Criteria for the Brugada Syndrome

Haplotype sharing test maps genes for familial cardiomyopathies

Recurrent and founder mutations in the Netherlands: Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia

Geographical distribution of plakophilin-2 mutation prevalence in patients with arrhythmogenic cardiomyopathy

The dawn of a new era in the struggle against sudden cardiac death

Genetic and molecular basis of cardiac arrhythmias : Impact on clinical management parts I and II

Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1)

The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update

Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study

Arrhythmogenic right ventricular cardiomyopathy: asymptomatic to life threatening as illustrated by the cases of two sisters

Atrial fibrillation: current knowledge and recommendations for management

Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation

The dawn of a new era in the struggle against sudden cardiac death

Genetic and molecular basis of cardiac arrhythmias : Impact on clinical management. Part III

Mortality and risk factors for malignant ventricular arrhythmias in carriers of the phospholamban R14del mutation

Can Implantable Cardioverter-Defibrillator Therapy Reduce Healthcare Costs?

Identification of the substrate of atrial vulnerability in patients with idiopathic atrial fibrillation

Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors

Infection after ICD implantation: operating room versus cardiac catheterisation laboratory

Suchergebnisse filtern